Skip to main content

AbbVie Inc.

ABBVNYSETrackedESG Rated: 2/2 ProvidersMarket Data VerifiedHealth CareBiotechnologyMSCI: BBBSustainalytics: 25.0 · Medium

Coverage
Rated universe Carries an MSCI or Sustainalytics observation.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 286.20

Up+USD 2.66 (+0.94%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 286.83
Previous close
USD 283.54
Day high
USD 290.23
Day low
USD 284.85
Volume
8,755,117
Market cap
USD 505,891,782,656
Price chart · 1 Year
AbbVie Inc. 1 Year price chartAbbVie Inc., nyse:ABBV, 1 Year price chart in USD. Start USD 232.91, end USD 286.01, high USD 295.03, low USD 197.38, up.
Period1 YearFirst closeUSD 232.91Last closeUSD 286.01Maximum closeUSD 295.03Minimum closeUSD 197.38Period change+USD 53.10Period percentage change+22.80%Chart as ofNov 18, 2026, 2:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 233.54 USD 238.15 USD 230.36 USD 232.91 7,618,400
USD 231.13 USD 231.54 USD 223.12 USD 224.13 9,365,900
USD 217.26 USD 219.82 USD 215.88 USD 219.26 5,816,400
USD 223.42 USD 223.96 USD 220.12 USD 223.26 6,767,700
USD 229.71 USD 232.55 USD 226.48 USD 226.92 5,410,900
USD 225.12 USD 227.81 USD 223.57 USD 225.37 7,607,000
USD 211.42 USD 213.49 USD 209.12 USD 209.40 5,654,000
USD 204.80 USD 210.42 USD 204.06 USD 210.26 6,199,400
USD 198.00 USD 201.42 USD 196.23 USD 197.38 7,467,600
USD 192.00 USD 205.83 USD 190.75 USD 203.89 10,406,300
USD 209.50 USD 213.51 USD 208.35 USD 210.77 5,006,500
USD 219.02 USD 219.60 USD 214.90 USD 217.72 7,618,500
USD 226.00 USD 226.50 USD 220.00 USD 221.59 5,261,900
USD 250.75 USD 251.80 USD 247.56 USD 251.06 6,988,000
USD 257.00 USD 260.96 USD 254.29 USD 254.49 6,872,400
USD 251.45 USD 256.20 USD 244.44 USD 245.10 7,435,600
USD 253.93 USD 259.18 USD 252.41 USD 258.92 5,010,200
USD 262.70 USD 262.97 USD 257.70 USD 261.72 4,225,200
USD 263.29 USD 266.34 USD 262.44 USD 263.96 8,176,600
USD 259.74 USD 264.06 USD 257.87 USD 262.82 5,861,400
USD 284.23 USD 287.93 USD 282.59 USD 282.68 4,171,300
USD 288.69 USD 291.32 USD 284.70 USD 286.00 5,367,600
USD 296.58 USD 297.25 USD 293.56 USD 295.03 3,261,200
USD 290.00 USD 292.55 USD 284.91 USD 286.01 4,839,300

Company Profile & Business Model Overview

AbbVie is a biopharmaceutical company known for Humira and newer immunology drugs. The company faces scrutiny over aggressive drug pricing and patent strategies despite patient assistance programs.

Sustainability Strengths & Catalysts (Pros)

  • Life-changing treatments for autoimmune and other diseases
  • 25% carbon emission reduction goal with renewable energy adoption
  • Strong compliance programs critical for pharma industry

Material Risks & Governance Concerns (Cons)

  • Aggressive Humira pricing and patent strategies drew major criticism
  • Drug affordability remains key social responsibility challenge

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

MSCI and Sustainalytics ratings shown side by side, never blended into a single score.

Third-party ratings

MSCI ESG Rating

BBB

MSCI ESG industry rating benchmark.Rating date not recorded

Sustainalytics Risk Score

25.0

MediumScore date not recorded

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is AbbVie Inc. (ABBV)'s ESG rating and sustainability score?

AbbVie Inc. (ABBV) currently holds an MSCI ESG rating of BBB and a Sustainalytics ESG Risk Score of 25.0 (Medium risk). Ratings evaluate environmental emissions, labor standards, board independence, and regulatory compliance.

Is AbbVie Inc. considered an ESG leader or laggard in Health Care?

AbbVie Inc. is classified as an Average ESG performer by MSCI with a BBB rating, indicating performance in line with mainstream sector peers with opportunities for further disclosure and risk management.

What are the main ESG risks and controversies for AbbVie Inc.?

Key material risks for AbbVie Inc. include: Aggressive Humira pricing and patent strategies drew major criticism; Drug affordability remains key social responsibility challenge. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.